| Reshma Kewalramani |
CEO & President, Director |
$68,635,180 |
+$3,895,768 |
+6% |
10 Feb 2026 |
| Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$36,982,840 |
|
|
10 Feb 2026 |
| Stuart A. Arbuckle |
Evp, Coo |
$28,590,654 |
|
|
01 Jul 2025 |
| BRUCE I. SACHS |
Director |
$24,847,329 |
+$1,948,416 |
+8.5% |
15 Jan 2026 |
| Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$23,682,677 |
-$8,501,278 |
-26% |
10 Feb 2026 |
| CHARLES F. WAGNER JR |
Evp, Co & Fo |
$22,614,834 |
-$12,427,252 |
-35% |
10 Feb 2026 |
| Carmen Bozic |
EVP and CMO |
$19,606,237 |
|
|
10 Feb 2026 |
| DAVID ALTSHULER |
EVP, Chief Scientific Officer |
$15,630,492 |
-$6,420,269 |
-29% |
22 Jan 2026 |
| JEFFREY M. LEIDEN |
Executive Chairman, Director |
$15,178,039 |
-$60,942,657 |
-80% |
22 Jan 2026 |
| Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13,426,165 |
|
|
05 May 2023 |
| Duncan McKechnie |
EVP, Chief Commercial Officer |
$10,216,490 |
|
|
10 Feb 2026 |
| Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$10,150,639 |
-$4,002,153 |
-28% |
10 Feb 2026 |
| Jonathan Biller |
EVP and Chief Legal Officer |
$9,585,692 |
-$2,076,687 |
-18% |
10 Feb 2026 |
| Mark E. Bunnage |
EVP, Chief Scientific Officer |
$5,945,993 |
-$930,529 |
-14% |
10 Feb 2026 |
| Kristen Ambrose |
SVP & Chief Accounting Officer |
$4,662,774 |
-$1,364,057 |
-23% |
10 Feb 2026 |
| Joy Liu |
SVP, General Counsel |
$4,025,167 |
|
|
15 Aug 2022 |
| Alan M. Garber |
Director |
$3,728,290 |
|
|
01 May 2025 |
| DIANA MCKENZIE |
Director |
$3,594,392 |
|
|
01 May 2025 |
| Terrence C. Kearney |
Director |
$3,139,773 |
|
|
01 May 2024 |
| MARGARET G. MCGLYNN |
Director |
$2,947,202 |
|
|
01 May 2023 |
| LLOYD CARNEY |
Director |
$2,632,155 |
|
|
19 Nov 2025 |
| Suketu Upadhyay |
Director |
$2,345,736 |
|
|
15 Jan 2026 |
| Sangeeta N. Bhatia |
Director |
$1,765,239 |
-$305,204 |
-15% |
27 Aug 2025 |
| Yuchun Lee |
Director |
$1,229,723 |
|
|
01 May 2023 |
| Nancy Thornberry |
Director |
$1,185,752 |
|
|
01 May 2025 |
| Jennifer Schneider |
Director |
$831,889 |
|
|
01 May 2025 |
| Michel Lagarde |
Director |
$400,731 |
|
|
01 May 2025 |